Rituximab therapy improves recalcitrant Pemphigus vulgaris

Pemphigus is a severe life-threatening blistering disease associated with autoantibodies against cell adhesion proteins desmogleins 1 and 3. Patients with severe pemphigus commonly show high rates of relapse after conventional immunosuppressive therapy. The newly developed drug Rituximab showed impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Noormohammadpour, Pedram, Ehsani, Amirhooshang, Mortazavi, Hossein, Daneshpazhooh, Maryam, Balighi, Kamran, Mofidi, Mohammad, Gholamali, Fatemeh, Sadeghinia, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553899/
https://www.ncbi.nlm.nih.gov/pubmed/26417354
http://dx.doi.org/10.17179/excli2014-603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553899/
https://www.ncbi.nlm.nih.gov/pubmed/26417354
http://dx.doi.org/10.17179/excli2014-603

Ejemplares similares